Seven Exciting Reasons UAE Families Are Exploring Newborn Stem Cell Banking
This is a collaborative post with Cells4Life.
Pregnancy brings a long list of decisions, from choosing a maternity hospital to preparing for the first weeks at home. Newborn stem cell banking gives families another positive choice: cells and tissues that are normally discarded after birth can instead be collected, processed and preserved as a resource for the future.
Here are seven reasons families in the UAE are exploring the opportunity.
Cells4Life offers four options in the UAE: cord blood, cord tissue, amnion and placenta banking.
Cord blood contains blood-forming stem cells, which have established uses in transplantation for certain disorders affecting blood and the immune system. Cord tissue contains different cells, including mesenchymal stromal cells, which are widely studied in regenerative medicine. The amnion is the innermost membrane surrounding the baby. The placenta contains several regions and cell types, including tissue originating from the baby and tissue originating from the mother.
These sources are complementary rather than interchangeable. Banking several types of material preserves a wider range of cells, allowing a family to look beyond one area of medicine and towards a broader landscape of potential applications.
Your baby’s own newborn cells are a 100% autologous match to your baby. Correctly isolated maternal cells are likewise a 100% autologous match to the mother. This provides immediate compatibility if a future treatment calls for the patient’s own cells.
The possibilities may reach further. Full biological siblings have a 25% chance of being a complete HLA match and a 50% chance of being a half-match. A parent and child are normally half-matched. Tissue typing and medical assessment confirm compatibility, but these natural family relationships can create valuable transplant options.
Collection takes place after birth and after the umbilical cord has been clamped, cut, and the placenta delivered. Cord blood is drawn from the cord, while cord tissue and placental materials are collected from tissues that would otherwise usually be discarded. Since the procedure takes place after the placenta has been delivered, there is no risk to mother or baby.
Delayed cord clamping and cord blood banking can go hand in hand. After clamping, the blood remaining in the cord can be collected and stored, while TotiCyte processing helps retain more of its stem cells. Reported to provide up to three times more stem cells at the point of treatment than standard processing, this technology allows parents to make the most of the cord blood they bank while honouring their delayed-clamping choice: the best of both worlds.
Blood-forming stem cells from cord blood are used in transplants for selected blood cancers, bone-marrow disorders, immune deficiencies and inherited metabolic or blood conditions. Whether a particular unit is suitable depends on factors such as diagnosis, cell count, viability, compatibility and patient size.
Alongside this established role, clinical researchers are studying stem cells in areas including cerebral palsy, autism, immune regulation and tissue repair. Cord tissue, amnion and placental cells also feature in regenerative-medicine research. These studies do not predict individual outcomes, but they show how scientists are working to extend the medical possibilities of cells collected at birth.
After collection, the samples travel to a specialist laboratory, where they are checked, prepared and frozen at extremely low temperatures. Careful processing helps retain the cells, while cryopreservation protects them during long-term storage. Every sample is individually identified, so its record stays connected to the baby or mother it came from.
The family also receives a record of what was stored. For cord blood, this includes measurements of the cells collected and their viability. That information gives doctors a useful starting point if the sample is ever considered for treatment.
The choice of bank matters as much as the choice of cells to store. Parents may want to look for a bank that can preserve several sources from the same birth and has invested in processing methods that retain as many viable cells as possible. That care at the collection and storage stages helps families make the most of the resources they have chosen to preserve.
Parents can also look at the bank’s experience supplying stored samples to hospitals, the standards its laboratory meets and how it transports cells for treatment. Together, these details show how well a bank can care for a family’s samples from collection through to their release for medical use.
Whether stem cell banking feels right for a family may depend on their medical history, their hopes for the future and what they can comfortably afford. For parents with a specific health concern, a transplant specialist or genetic counsellor can help them explore the decision in light of their family’s circumstances.
For many parents, banking feels a little like an insurance policy: they hope they will never need to call on it, but gain peace of mind from preserving cells that are available only at birth. It is also a forward-looking choice. As researchers continue to explore new uses for newborn and placental cells, families who have stored them retain a personal resource to bring into conversations about the therapies of tomorrow.
Making arrangements before the due date means the collection plan can become part of the birth preparations. When the day arrives, parents can focus on meeting their baby, knowing they have taken a thoughtful step for the future.
Find our more about stem cell banking with Cells4Life at Cells4Life.ae
We accept Guest Posts 
|
|
New
Review
Abu Dhabi International Airport - 41°F
